Abstract 4948: MDM2 antagonism overcomes resistance to CDK4/6 inhibition in melanoma
Anna E. Vilgelm(The Ohio State University), Ann Richmond(Monroe Carell Jr. Children's Hospital), Douglas B. Johnson(Vanderbilt University Medical Center), Rondi M. Kauffman(Vanderbilt University), Gregory D. Ayers(Vanderbilt University Medical Center), Kelsie Riemenschneider(The University of Texas Southwestern Medical Center), Nabil Saleh(Ain Shams University), Sheau-Chian Chen(Vanderbilt University Medical Center), Lauren Slesur(Vanderbilt University), Mark C. Kelley(Vanderbilt University)
Cited by 0
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917